Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Extracorporeal Shock Wave Therapy and Assessment Strategy Through a Novel Gait Analysis Tool for Post-stroke Spasticity During COVID-19 Pandemic

NCT05206240 is registered in ClinicalTrials.gov with Carol Davila University of Medicine and Pharmacy as lead sponsor.

NCT NCT05206240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05206240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Extracorporeal Shock Wave Therapy and Assessment Strategy Through a Novel Gait Analysis Tool for Post-stroke Spasticity During COVID-19 Pandemic
Lead sponsor
Carol Davila University of Medicine and Pharmacy
Phase
Observational
Overall status
Completed
Start date
March 1, 2021
Completion date
August 1, 2022
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spastic gait, spasticity, muscle, stroke hemorrhagic, stroke, ischemic